0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts
Elizabeth A. Rafferty, MD; Melissa A. Durand, MD; Emily F. Conant, MD; et al.
JAMA Oncology
Invited Commentary  | 
Adjuvant Trastuzumab Benefit in Patients Diagnosed With Triple-Positive Breast Cancer
Anne F. Schott, MD
JAMA Oncology
Research Letter  | 
Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy
Kathleen Van Dyk, PhD; Laura Petersen, MS; Patricia A. Ganz, MD
JAMA Oncology
Original Investigation  | 
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HERA Trial
Sherene Loi, MD, PhD; Urania Dafni, ScD; Dimitris Karlis, PhD; et al.